References
1. Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733.
2. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062.
3. Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med.2020.
4. Shaker MS, Oppenheimer J, Grayson M, et al. COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic. J Allergy Clin Immunol Pract. 2020.
5. Johnston SL. Asthma and COVID-19: is asthma a risk factor for severe outcomes? Allergy. 2020.
6. Hegde S. Does asthma make COVID-19 worse? Nat Rev Immunol.2020.
7. Williamson PO, Minter CIJ. Exploring PubMed as a reliable resource for scholarly communications services. J Med Libr Assoc.2019;107(1):16-29.
8. Carli G, Cecchi L, Stebbing J, Parronchi P, Farsi A. Is asthma protective against COVID-19? Allergy. 2020.
Natália F. Mendes1,2 , Carlos P. Jara1,2 , Eli Mansour3, Eliana P. Araújo1,2 , Licio A. Velloso2,3*
1School of Nursing, State University of Campinas, Campinas, Brazil
2Laboratory of Cell Signaling, Obesity and Comorbidities Research Center, State University of Campinas, Campinas, Brazil
3Clinical Immunology and Allergy, Department of Internal Medicine, State University of Campinas, Campinas, Brazil